MedPath

Homoeopathic management of Chronic Urticaria

Phase 2
Conditions
Health Condition 1: L509- Urticaria, unspecified
Registration Number
CTRI/2024/02/062602
Lead Sponsor
Central Council for Research in Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Male and Female aged 18 to 50 years.

2.Patients clinically diagnosed with chronic urticaria, characterized by central swelling surrounded by erythema and itching.

3.lesions occurring at least for a period of 6 weeks and for which taking conventional treatment atleast twice in a week.

4.All patients provided written informed consent.

Exclusion Criteria

1.Patients with acute (urticaria less than 6 weeks),angioedema with no urticaria, urticarial vasculitis and associated psychiatric diseases.

2.History of Bronchial Asthma.

3.Pregnant or lactating women.

4.Cases with urticaria vasculitis, angioedema, systemic diseases like cardiovascular, endocrinal diseases, psychiatric diseases or systemic infections or on other treatment therapies.

5. Patients taking steroids or any other medications.

6. Severely ill patients and immunocompromised patients.

7. Patients non willing to compliance.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease of symptoms ( pruritus, redness, burning) with decrease of UAS7 score.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
1.To assess the changes in the dependency on anti-allergic medicines in verum and placebo groups. <br/ ><br>2.To assess the changes in the total and individual domain scores of CU QoL. <br/ ><br>3.To assess the changes in AEC, total IgE level, Specific IgE <br/ ><br>4.To know the acute exacerbation of the diseases in the form of frequency, duration and intensity in both group <br/ ><br>Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath